Document is current
Any future updates will be listed below
-
Authors
Merkel, Jonathan
Perneczky, Robert
Jessen, Frank
Frölich, Lutz
Jansen, Olav
Peters, Sönke
Berg, Daniela
Schulz, Jörg B.
Bartsch, Thorsten
-
Funding
Funding for this research was provided by:
Universitätsklinikum Schleswig-Holstein - Campus Kiel
- License Information
-
More Information
Article History
Received: 6 January 2026
Accepted: 23 March 2026
First Online: 28 March 2026
Declarations
:
: Not applicable.
: Not applicable.
: J.M. has no competing interests to declare. R.P. has received honoraria for advisory boards and speaker engagements from Roche, Eisai, Eli Lilly, Biogen, Janssen-Cilag, AstraZeneca, Schwabe, Grifols, Novo Nordisk, and Tabuk. R.P. is a member of the Steering Committee of the German Network of Memory Clinics. F.J. has received consulting fees, honoraria for advisory boards, speaker engagements, and expert testimony from Eisai, Eli Lilly, Roche, Novo Nordisk, and AC Immune. F.J. has received institutional grants from Roche Pharma. F.J. is chairman of the EADC and board member of the German Network of Memory Clinics and InRAD. L.F. has received consulting fees from Avanex, Biogen, BioVie, Bristol-Myers Squibb, Charles-River Ass., Eli Lilly, Eisai, GE Healthcare, Grifols, Janssen-Cilag, Janssen Research, Neurimmune, Noselab, NovoNordisk, Roche, TauRX, and Schwabe. L.F. has received honoraria for advisory boards, speaker engagements, and expert testimony from Eli Lilly, Eisai, DerCampus, Medscape, Medfora, FOMF, NovoNordisk, Roche, Schwabe, Neuroscios, ReMynd, Otsuka/Avanir, and Vivoryon. L.F. has received institutional grants from Hoffmann-La Roche. L.F. is a board member of the German Society of Psychiatry, Psychotherapy and Nervous Diseases, the European Alzheimer Disease Consortium, the German Network of Memory Clinics, Alzheimer Europe, and Alzheimer Society Baden-Württemberg. O.J. has received honoraria for speaker engagements from Stryker GmbH and Philips. S.P. has received honoraria for speaker engagements from Bayer and Stryker GmbH. D.B. is the current president of the German Society of Neurology. J.B.S. has received consulting fees, honoraria for advisory boards and speaker engagements from Biogen, Eli Lilly, Reata, and Eisai. J.B.S. has received institutional grants from Biogen, Eli Lilly, and Eisai. J.B.S. is a board member of the German Network of Memory Clinics and speaker of the Commission “Dementia” of the German Society of Neurology. T.B. has received consulting fees, honoraria for advisory boards and speaker engagements from Roche, EISAI, Eli Lilly, Biogen, BMS, Pfizer, Novo Nordisk. T.B. is a member of the Steering Committee of the German Network of Memory Clinics.
